XJPX
2927
Market cap78mUSD
Dec 05, Last price
857.00JPY
1D
-0.46%
1Q
-1.04%
Jan 2017
4.90%
IPO
-38.79%
Name
AFC-HD AMS Life Science Co Ltd
Chart & Performance
P/E
9.63
P/S
0.40
EPS
89.01
Div Yield, %
3.48%
Shrs. gr., 5y
—
Rev. gr., 5y
13.18%
Revenues
30.19b
+18.01%
Net income
1.25b
+13.56%
CFO
1.54b
+77.99%
Dividend
Aug 28, 20250 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and supplements. It plans, researches, develops, and processes, as well as completes dietary supplement and cosmetics. The company offers health foods in various forms, such as tablets, soft and hard capsules, granules, soft drinks, and jellies. Its cosmetic products include facial cleansing, lotions, milky lotions, makeup oils, cleansing creams, and liquid cosmetics.. The company also wholesales dietary supplements and cosmetics; collects health-related information; plans and produces TV commercials, TV shopping channels, and video packages; publishes health magazines; and operates day and night care center under the Hello House name, and prep school under the Hello Gakuen name. In addition, it sells dietary supplements and cosmetics through mail orders; operates Internet shops; offers Kanpou, a general practitioner medicine for medical care; and produces and sells health care merchandise. The company operates in Japan, rest of Asia, and internationally. The company was formerly known as AMS Life Science Co., Ltd. and changed its name to AFC-HD AMS Life Science Co., Ltd. in March 2010. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | 2016‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||